Keywords: roche, files, europe, xeloda/taxotere, combination, filed, approval

Roche files in Europe for Xeloda/Taxotere combination

Article | 10 April 2001

Print This

Roche has filed for approval in the European Union to use its oralcancer drug Xeloda (capecitabine) in combination with Aventis' ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in